May #144 : Cardio Risk Raiser

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents
 

HIV: Behind the Music

Taking Care of Business




Not by Meds Alone

No Viral Load=No Transmission?

The Stand

Staphing Up

Mixology

Heads of the Class

Heartburn Hotel

Protein Shakers

Mercury Rising

Britain: Hep C Rings Twice

Pill-Taking Tip

Cardio Risk Raiser

Cholesterol Downer




What's a Girl to Do?

Runaway Hit

The Mother of All HIV Tests

Lights! Camera! Bareback Action!

Prom Night Prep

Apply as Directed

Strong-arming HIV

Healing Fields

Jargon: DWI

Keeping Up With the Joneses

Melrose Place 2.0

Silence=Meth

Rock Out

Ladies First




Editor's Letter-May 2008

Mailbox-May 2008



 
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


Scroll down to comment on this story.


email print

May 2008


Cardio Risk Raiser

A large international HIV study announced some unexpected results in January: The antiviral meds abacavir (Ziagen, also in Epzicom and Trizivir) and didanosine (Videx) raised the risk of heart attack. In the study (Data Collection on Adverse Events of HIV Drugs or D:A:D), abacavir and didanosine lifted heart attack risk among participants by 90 and 49 percent, respectively.

The increase likely poses the most danger to those with other risk factors like smoking, diabetes or high blood pressure. For those whose initial risk level is small, the raise may prove insignificant. In D:A:D, the effect applied only to current users of the meds: When people switched the meds, the increase disappeared too.

For more info, search POZ.com for our special report: “Reckoning the Risk: Abacavir, Didanosine and Heart Disease Risk.”


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Hide comments

Previous Comments:


         

[Go to top]

Join POZ Facebook Twitter Google+ MySpace YouTube Tumblr Flickr
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    dlw8585
    Fort Lauderdale
    Florida


    koffeeboss
    Tucson
    Arizona


    Sexynyrican
    Brooklyn
    New York


    thebake
    Sioux Falls
    South Dakota
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.